Spectrum of tau pathologies in Huntington's disease.
Journal
Laboratory investigation; a journal of technical methods and pathology
ISSN: 1530-0307
Titre abrégé: Lab Invest
Pays: United States
ID NLM: 0376617
Informations de publication
Date de publication:
07 2019
07 2019
Historique:
received:
26
09
2018
accepted:
31
10
2018
revised:
26
09
2018
pubmed:
24
12
2018
medline:
19
5
2020
entrez:
22
12
2018
Statut:
ppublish
Résumé
Huntington's disease (HD) is an autosomal dominant disorder caused by a trinucleotide expansion in the huntingtin gene. Recently, a new role for tau has been implicated in the pathogenesis of HD, whereas others have argued that postmortem tau pathology findings are attributable to concurrent Alzheimer's disease pathology. The frequency of other well-defined common age-related tau pathologies in HD has not been examined in detail. In this single center, retrospective analysis, we screened seven cases of Huntington's disease (5 females, 2 males, age at death: 47-73 years) for neuronal and glial tau pathology using phospho-tau immunohistochemistry. All seven cases showed presence of neuronal tau pathology. Five cases met diagnostic criteria for primary age-related tauopathy (PART), with three cases classified as definite PART and two cases as possible PART, all with a Braak stage of I. One case was diagnosed with low level of Alzheimer's disease neuropathologic change. In the youngest case, rare perivascular aggregates of tau-positive neurons, astrocytes and processes were identified at sulcal depths, meeting current neuropathological criteria for stage 1 chronic traumatic encephalopathy (CTE). Although the patient had no history of playing contact sports, he experienced several falls, but no definitive concussions during his disease course. Three of the PART cases and the CTE-like case showed additional evidence of aging-related tau astrogliopathy. None of the cases showed significant tau pathology in the striatum. In conclusion, while we found evidence for tau hyperphosphorylation and aggregation in all seven of our HD cases, the tau pathology was readily classifiable into known diagnostic entities and most likely represents non-specific age- or perhaps trauma-related changes. As the tau pathology was very mild in all cases and not unexpected for a population of this age range, it does not appear that the underlying HD may have promoted or accelerated tau accumulation.
Identifiants
pubmed: 30573872
doi: 10.1038/s41374-018-0166-9
pii: S0023-6837(22)02613-7
pmc: PMC9342691
mid: NIHMS1511352
doi:
Substances chimiques
tau Proteins
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1068-1077Subventions
Organisme : NIA NIH HHS
ID : P50 AG005133
Pays : United States
Références
Sci Rep. 2013;3:2388
pubmed: 23925123
Acta Neuropathol. 2015 Dec;130(6):891-3
pubmed: 26497674
Acta Neuropathol. 2016 Jan;131(1):87-102
pubmed: 26659578
J Huntingtons Dis. 2014;3(2):209-17
pubmed: 25062863
Brain. 2015 Jul;138(Pt 7):1907-18
pubmed: 25953777
Acta Neuropathol. 2015 Dec;130(6):877-89
pubmed: 26518018
Sci Rep. 2016 Oct 14;6:35236
pubmed: 27739513
J Biol Chem. 2008 Mar 7;283(10):6489-500
pubmed: 18167354
J Mol Neurosci. 2011 Nov;45(3):453-66
pubmed: 21881826
Handb Clin Neurol. 2008;89:599-618
pubmed: 18631782
Acta Neuropathol. 2009 Nov;118(5):605-16
pubmed: 19669651
J Neural Transm (Vienna). 1998;105(8-9):787-99
pubmed: 9869319
Brain. 2013 Jan;136(Pt 1):43-64
pubmed: 23208308
J Neuropathol Exp Neurol. 2008 Dec;67(12):1159-65
pubmed: 19018245
J Neuropathol Exp Neurol. 2017 Apr 1;76(4):270-288
pubmed: 28340083
Nat Med. 2014 Aug;20(8):881-5
pubmed: 25038828
Science. 2009 Feb 27;323(5918):1208-1211
pubmed: 19251628
Sci Rep. 2012;2:603
pubmed: 22934129
Neurobiol Aging. 1997 Jul-Aug;18(4 Suppl):S1-2
pubmed: 9330978
Acta Neuropathol. 2012 Nov;124(5):749-60
pubmed: 22735976
Acta Neuropathol. 2016 Jan;131(1):75-86
pubmed: 26667418
Curr Opin Neurol. 2014 Aug;27(4):477-83
pubmed: 24978638
Brain Pathol. 2017 Sep;27(5):675-690
pubmed: 28805003
Brain. 2009 Nov;132(Pt 11):2922-31
pubmed: 19674978
Science. 2009 Feb 27;323(5918):1205-8
pubmed: 19251627
Acta Neuropathol. 2018 Feb;135(2):249-265
pubmed: 29134321
Lancet Neurol. 2010 Oct;9(10):995-1007
pubmed: 20864052
J Geriatr Psychiatry Neurol. 2010 Dec;23(4):243-59
pubmed: 20923757
Acta Neuropathol. 2007 Jul;114(1):5-22
pubmed: 17579875
Hum Mol Genet. 2010 Apr 15;19(R1):R46-64
pubmed: 20400460
J Neuropathol Exp Neurol. 2011 Nov;70(11):960-9
pubmed: 22002422
J Neuropathol Exp Neurol. 1985 Nov;44(6):559-77
pubmed: 2932539
Acta Neuropathol. 2014 Dec;128(6):755-66
pubmed: 25348064
Hum Mol Genet. 2015 Jan 1;24(1):76-85
pubmed: 25143394
Nat Neurosci. 2012 Nov;15(11):1488-97
pubmed: 23023293
J Neuropathol Exp Neurol. 1988 Sep;47(5):516-25
pubmed: 2971785
Sci Rep. 2012;2:529
pubmed: 22829983
Brain. 2016 Apr;139(Pt 4):1014-25
pubmed: 26969684
Cell. 1993 Mar 26;72(6):971-83
pubmed: 8458085
J Neuropathol Exp Neurol. 1998 May;57(5):369-84
pubmed: 9596408
EMBO Rep. 2012 Aug;13(8):759-64
pubmed: 22710833
Cell Rep. 2017 Jan 31;18(5):1118-1131
pubmed: 28147269
Brain Pathol. 2010 May;20(3):589-97
pubmed: 19832837
J Neuropathol Exp Neurol. 2016 Oct;75(10):963-970
pubmed: 27543120
Alzheimers Dement. 2012 Jan;8(1):1-13
pubmed: 22265587
Acta Neuropathol. 2012 Jan;123(1):1-11
pubmed: 22101365
Science. 1997 Sep 26;277(5334):1990-3
pubmed: 9302293
Acta Neuropathol. 2014 Dec;128(6):767-72
pubmed: 25359108
Acta Neuropathol Commun. 2018 Jun 11;6(1):50
pubmed: 29891013
Neurosci Lett. 2000 Jul 28;289(1):29-32
pubmed: 10899401